Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER_GOV 1 OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 2 Sleep Initiation and Maintenance Disorders 1 Fatigue 1 Depression 1 Adenocarcinoma 1

Interventions

Gefitinib 3 Capecitabine 2 darolutamide 1 XELOX 1 Tegafur 1 Surgical Procedures, Operative 1 Oxaliplatin 1 Leucovorin 1 Fluorouracil 1 Endoscopy 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Adenocarcinoma × darolutamide × Clear all

NCT07617272 2026-06-01

PARIS-BIO

Region Stockholm

Phase 2 Recruiting

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡